ロード中...
Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization
Erythropoietin (EPO) is a well-known hormone that is clinically used for the treatment of anemia. Very recently, an increasing body of evidence showed that EPO could still regulate bioactivities of macrophages. However, the details about the immunomodulatory effect of EPO on macrophages are not full...
保存先:
| 出版年: | Cell Death Dis |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477572/ https://ncbi.nlm.nih.gov/pubmed/28383559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.104 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|